Literature DB >> 17390095

Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.

Seth C Kalichman1, Christina M Amaral, Heidi Stearns, Denise White, Jody Flanagan, Howard Pope, Chauncey Cherry, Demetria Cain, Lisa Eaton, Moira O Kalichman.   

Abstract

BACKGROUND: Unannounced pill counts conducted in patients' homes is a valid objective method for monitoring medication adherence that is unfortunately costly and often impractical. Conducting unannounced pill counts by telephone may be a viable alternative for objectively assessing medication adherence.
PURPOSE: To test an unannounced pill count assessment of adherence conducted by telephone.
METHODS: HIV-positive men and women (N = 77) in Atlanta GA completed an unannounced telephone-based pill count immediately followed by a pill count conducted in an unannounced home visit.
RESULTS: A high degree of concordance was observed between phone and home-based number of pills counted (Intraclass correlation, ICC = .997, 95% CI .995-.998, P < .001) and percent of pills taken (ICC = .990, 95% CI .986-.992, P < .001). Concordance between adherence above/below 90% and phone/home counts was 95%, Kappa coefficient = .995. Concordance between pill counts was not influenced by participant education or health literacy and was maintained when the data were censored to remove higher levels of adherence. Analyses of discordant pill counts found the most common source of error resulted from overcounted doses in pillboxes on the telephone.
CONCLUSIONS: Unannounced phone-based pill counts offer an economically and logistically feasible objective method for monitoring medication adherence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390095      PMCID: PMC2219717          DOI: 10.1007/s11606-007-0171-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

1.  Is the influence of social desirability on patients' self-reported adherence overrated?

Authors:  Glenn Wagner; Loren G Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

Review 2.  The concordance of self-report with other measures of medication adherence: a summary of the literature.

Authors:  Mathew C Garber; David P Nau; Steven R Erickson; James E Aikens; Joseph B Lawrence
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

3.  Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Authors:  Cheryl A Liechty; Christopher S Alexander; P Richard Harrigan; J David Guzman; Edwin D Charlebois; Andrew R Moss; David R Bangsberg
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177

Review 4.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

5.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

6.  Provider assessment of adherence to HIV antiretroviral therapy.

Authors:  D R Bangsberg; F M Hecht; H Clague; E D Charlebois; D Ciccarone; M Chesney; A Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

7.  Barriers to use of electronic adherence monitoring in an HIV clinic.

Authors:  C S Wendel; M J Mohler; K Kroesen; N M Ampel; A L Gifford; S J Coons
Journal:  Ann Pharmacother       Date:  2001-09       Impact factor: 3.154

8.  Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Authors:  Jessica H Oyugi; Jayne Byakika-Tusiime; Edwin D Charlebois; Cissy Kityo; Roy Mugerwa; Peter Mugyenyi; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

9.  Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.

Authors:  Thomas P Giordano; David Guzman; Richard Clark; Edwin D Charlebois; David R Bangsberg
Journal:  HIV Clin Trials       Date:  2004 Mar-Apr

10.  The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills.

Authors:  R M Parker; D W Baker; M V Williams; J R Nurss
Journal:  J Gen Intern Med       Date:  1995-10       Impact factor: 5.128

View more
  70 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

2.  Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.

Authors:  Taneisha S Buchanan; Carla J Berg; Lisa Sanderson Cox; Niaman Nazir; Neal L Benowitz; Lisa Yu; Olivia Yturralde; Peyton Jacob; Won S Choi; Jasjit S Ahluwalia; Nicole L Nollen
Journal:  Nicotine Tob Res       Date:  2012-02-24       Impact factor: 4.244

3.  Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christopher Kegler; Chauncey Cherry; Moira O Kalichman
Journal:  J Behav Med       Date:  2015-04-03

4.  A pilot clinical trial of varenicline for smoking cessation in black smokers.

Authors:  Nicole L Nollen; Lisa Sanderson Cox; Niaman Nazir; Edward F Ellerbeck; Ashli Owen; Sydni Pankey; Nia Thompson; Jasjit S Ahluwalia
Journal:  Nicotine Tob Res       Date:  2011-04-15       Impact factor: 4.244

5.  Sexual HIV transmission and antiretroviral therapy: a prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS.

Authors:  Seth C Kalichman; Chauncey Cherry; Denise White; Miche'l Jones; Tamar Grebler; Moira O Kalichman; Mervi Detorio; Angela M Caliendo; Raymond F Schinazi
Journal:  Ann Behav Med       Date:  2011-08

Review 6.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

7.  A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients.

Authors:  Daniel Cukor; Nisha Ver Halen; Melissa Pencille; Fasika Tedla; Moro Salifu
Journal:  Nephron       Date:  2016-09-07       Impact factor: 2.847

8.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

9.  A simple single-item rating scale to measure medication adherence: further evidence for convergent validity.

Authors:  Seth C Kalichman; Christina M Amaral; Connie Swetzes; Michelle Jones; Rene Macy; Moira O Kalichman; Chauncey Cherry
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009 Nov-Dec

10.  Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.

Authors:  Seth C Kalichman; Tamar Grebler; Christina M Amaral; Megan McNerey; Denise White; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  J Gen Intern Med       Date:  2012-10-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.